Bangkok Genomics Innovation PCL (BKK:BKGI)

Thailand · Delayed Price · Currency is THB

2.380

+0.040 (1.71%)

Oct 9, 2026, 4:38 PM ICT

Market Cap	1.43B +46.9%
Revenue (ttm)	538.69M +62.3%
Net Income	95.06M +143.0%
EPS	0.16 +143.0%
Shares Out	600.00M
PE Ratio	14.77
Forward PE	n/a
Dividend	0.05 (2.10%)
Ex-Dividend Date	May 6, 2026

Volume	239,800
Open	2.360
Previous Close	2.340
Day's Range	2.340 - 2.400
52-Week Range	1.200 - 2.480
Beta	1.31
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About BKK:BKGI

Bangkok Genomics Innovation Public Company Limited provides medical analysis services in Thailand. The company offers screening for fetal chromosomal abnormalities using non-invasive prenatal testing under the NIFTY brand, preimplantation chromosomal abnormality and thalassemia carrier gene screening, infectious disease group analysis, and monkeypox virus analysis. It also provides other screening tests, such as cancer-related gene screening to predict the risk of inherited cancer, monitor treatment, select drugs that are appropriate for one's ... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 2017

Country Thailand

Stock Exchange Stock Exchange of Thailand

Ticker Symbol BKGI

Full Company Profile

Financial Performance

In 2025, BKK:BKGI's revenue was 379.51 million, an increase of 12.42% compared to the previous year's 337.59 million. Earnings were 45.35 million, a decrease of -9.61%.

Financial Statements